Inflammatory mediators IL-1β, TNF-α, and IL-6 are increased at the early onset of colorectal cancer, and inhibiting the production of these cytokines can be an effective strategy to prevent colon cancer development [31]. This evidence concerns the gene TNF and colorectal cancer.